A large national database study presented at CROI 2026 in Denver, CO, reports that 5-year survival remains lower for people with HIV compared with people without HIV across most treatment modalities for...
Recent studies examine metformin for long COVID prevention, resistance exercise for post-COVID recovery, mRNA vaccines in cancer care, and vascular risks in children.
A randomized clinical trial tested whether a digital health program delivered directly to patients could increase lung cancer screening rates among eligible adults. Conducted at two academic health systems,...
The FDA approved Zongertinib for adults with unresectable or metastatic non-squamous NSCLC with HER2 (ERBB2) TKD activating mutations following prior systemic therapy.
Neoadjuvant nivolumab plus ipilimumab demonstrated improved event-free survival, higher pathologic complete response rates, and lower toxicity compared with chemotherapy in patients with resectable...
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
In their presentation at the 48th ONS Congress, in San Antonio, Texas, Kathy Waitman DNP, APN-BC, AOCNP and Shaunna Kersten CNS, MSN, ANP identified the best imaging modalities based on common oncologic...
In a new study, investigators examined the impact of the expanded lung cancer screening criteria on the mortality rate of high-risk patient populations.
The American College of Chest Physicians has released new guidelines on screening patients for lung cancer after a review of current literature was performed.
